Gastric Neoplasm: Clinical Trials

4 trials for Gastric Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 32Not yet recruiting 1, Recruiting 1

Follow Gastric Neoplasm: new trials by email Literature Review of Gastric Neoplasm trials Research Report on Gastric Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Fruquintinib Combined with Sintilimab and Stereotactic Body Radiation Therapy - Gastric Neoplasm
Phase 2 / Phase 3Not yet recruitingQueling Liu302025-06-012025-05-16
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer
Phase 2 / Phase 3RecruitingUkrainian Society of Clinical Oncology1502025-03-252025-05-06
Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
S-1 de-escalation, Chemotherapy by Investigator's choice - Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric Neoplasm
Phase 2CompletedAIO-Studien-gGmbH2422014-09-012021-03-26
Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer
Omegaven - Esophageal Neoplasm, Gastric Neoplasm
Phase 2TerminatedUniversity Hospitals, Leicester212012-05-012016-05-26

Narrower conditions

Stomach Neoplasms (4)  ·  Adenocarcinoma Of Esophagus (2)  ·  Esophageal Neoplasms (2)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Broader conditions

Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Gastrointestinal Diseases (4)  ·  Neoplasms by Site (4)  ·  Stomach Diseases (4)  ·  Gastrointestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Esophageal Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Docetaxel (2)  ·  Fluorouracil (2)  ·  Leucovorin (2)  ·  Oxaliplatin (2)  ·  Capecitabine (1)  ·  Cisplatin (1)  ·  Epirubicin (1)  ·  Fish Oils (1)  ·  Radiosurgery (1)  ·  S 1 (combination) (1)  ·  fish oil triglycerides (1)  ·  sintilimab (1)  ·  tegafur-gimeracil-oteracil (1)

Sponsors

AIO-Studien-gGmbH (1)  ·  Queling Liu (1)  ·  Ukrainian Society of Clinical Oncology (1)  ·  University Hospitals, Leicester (1)

Countries

Germany (1)  ·  Lithuania (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

David J Bowrey, MD (1)  ·  Georg Martin Haag, Dr. (1)  ·  Mykyta Pepenin, MD (1)

Results publications

PMID 27342748, PMID 28760152, PMID 37270871